Lobbying Filing Details

Total Spending

$520,000

Activities

5

Lobbyists

4

Gov't Entities

11

Filing Information
Filing UUID:
3d4362f4-9c70-4b9f-9e66-32252ba5c91d
Type:
Q1 - 1st Quarter - Report
Period:
2022 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2022 at 7:59 PM
Income:
$0
Expenses:
$520,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Samantha Ventimiglia
Registrant
VERTEX PHARMACEUTICALS INCORPORATED

Global biotechnology company

Boston, Massachusetts
Client
VERTEX PHARMACEUTICALS INCORPORATED
Massachusetts, United States of America
Lobbying Activities (5)
Activity 1
Budget/Appropriations

Issues related to funding for the Food and Drug Administration (S 2599 and HR 4356: "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022.")

Lobbyists (1)
  • SCOTT BARNES
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Health Issues

Issues related to FDA regulatory pathways for pharmaceuticals (no specific bills); Issues related to pharmaceutical pricing, health care cost and price transparency: HR 3, "Elijah E. Cummings Lower Drug Costs Now Act"; HR 19, "Lower Costs, More Cures Act"; S 2164, "Lower Costs, More Cures Act." Issues related to health care and prescription drug pricing in HR 5376, "Build Back Better Act"; H.R.5801 - HELP Copays Act.

Lobbyists (4)
  • SAMANTHA VENTIMIGLIA
  • SCOTT BARNES
  • MATTHEW O SCHUMAKER
  • KWAMME ANDERSON
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
Activity 3
Medical/Disease Research/Clinical Labs

General education about FDA approval policies and NIH research activities. Policies related to the reauthorization of the Prescription Drug User Fee Act. Policies related to the FDA in S. 1260, "US Innovation and Competition Act," and HR 4521, "America COMPETES Act." Issues related to platform technologies and other FDA-related provisions in S. 3799, "PREVENT Pandemics Act."

Lobbyists (4)
  • SAMANTHA VENTIMIGLIA
  • SCOTT BARNES
  • MATTHEW O SCHUMAKER
  • KWAMME ANDERSON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 4
Medicare/Medicaid

Issues related to rare disease and orphan disease patient access in Medicaid (no specific bills).

Lobbyists (4)
  • SAMANTHA VENTIMIGLIA
  • SCOTT BARNES
  • MATTHEW O SCHUMAKER
  • KWAMME ANDERSON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 5
Taxation/Internal Revenue Code

Issues related to corporate and international tax policy and research and development tax credits (no specific bills). Issues related to the Orphan Drug Tax Credit. Issues related to corporate and international tax policy in HR 5376, "Build Back Better Act."

Lobbyists (4)
  • SAMANTHA VENTIMIGLIA
  • SCOTT BARNES
  • MATTHEW O SCHUMAKER
  • KWAMME ANDERSON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.